Cantor Fitzgerald Initiates Coverage on Viking Therapeutics (NASDAQ:VKTX)
Analysts at Cantor Fitzgerald started coverage on shares of Viking Therapeutics (NASDAQ:VKTX – Get Free Report) in a research report issued on Monday, MarketBeat Ratings reports. The brokerage set an “overweight” rating and a $104.00 price target on the biotechnology company’s stock. Cantor Fitzgerald’s price target would indicate a potential upside of 272.23% from the […]
Analysts at Cantor Fitzgerald started coverage on shares of Viking Therapeutics (NASDAQ:VKTX – Get Free Report) in a research report issued on Monday, MarketBeat Ratings reports. The brokerage set an “overweight” rating and a $104.00 price target on the biotechnology company’s stock. Cantor Fitzgerald’s price target would indicate a potential upside of 272.23% from the […]
